Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

1.1K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

102
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
102
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

8.2K
The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
8.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building Intelligent ECG.

IEEE pulse·2026
Same authorSame journal

Benefits for Early Diagnosis, Treatment, and Research.

IEEE pulse·2026
Same author

Suite of Ingestible Devices Opens Window to the Gut Nervous System, Microbiome.

IEEE pulse·2026
Same author

Urine-Based Spectroscopy/AI Platform for Early Detection of Multiple Cancers.

IEEE pulse·2026
Same author

From Promise to Practice: Building the Open Infrastructure for Health Wearables.

IEEE pulse·2026
Same author

Beyond the Mask: Nerve Stimulation and Other Breakthroughs for Sleep Apnea.

IEEE pulse·2025
Same journal

The Heart of the Metaverse: How Immersive Technologies Are Revolutionizing Cardiac Care.

IEEE pulse·2026
Same journal

At the Crossroads of Innovation.

IEEE pulse·2026
Same journal

Robotics in the Cath Lab: Precision, Safety, and the Rise of Remote Cardiac Interventions.

IEEE pulse·2026
Same journal

Industry Corner Live With BioBeat CEO Arik Ben Ishay.

IEEE pulse·2026
Same journal

Engineering the Next Generation of Artificial Hearts.

IEEE pulse·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

5.2K

Results in a Week to a Month.

Leslie Mertz

    IEEE Pulse
    |March 6, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Researchers developed microtumors on a chip to rapidly test cancer therapies. This innovative approach may also predict cancer metastasis, accelerating treatment development.

    Area of Science:

    • Oncology
    • Biotechnology
    • Medical Diagnostics

    Background:

    • Traditional cancer therapy testing is time-consuming and can be ineffective.

    More Related Videos

    Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil Ers4tU
    11:46

    Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil Ers4tU

    Published on: August 22, 2019

    11.7K
    Rapid Verification of Terminators Using the pGR-Blue Plasmid and Golden Gate Assembly
    09:51

    Rapid Verification of Terminators Using the pGR-Blue Plasmid and Golden Gate Assembly

    Published on: April 25, 2016

    8.1K

    Related Experiment Videos

    Last Updated: Mar 8, 2026

    Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
    08:05

    Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

    Published on: December 9, 2022

    5.2K
    Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil Ers4tU
    11:46

    Extremely Rapid and Specific Metabolic Labelling of RNA In Vivo with 4-Thiouracil Ers4tU

    Published on: August 22, 2019

    11.7K
    Rapid Verification of Terminators Using the pGR-Blue Plasmid and Golden Gate Assembly
    09:51

    Rapid Verification of Terminators Using the pGR-Blue Plasmid and Golden Gate Assembly

    Published on: April 25, 2016

    8.1K
  • Predicting cancer metastasis remains a significant clinical challenge.
  • Patient-derived models are crucial for personalized medicine.